Endometritis: The missing diagnosis behind pelvic pain
Endometritis keeps surfacing in patient forums as the condition doctors still miss after years of pelvic pain workups. Standard imaging rarely catches it, and many women leave appointments with vague labels while low-grade inflammation lingers. Recent reviews in reproductive medicine now flag chronic endometritis as a concrete explanation that finally fits the timeline.
Clinical profile of chronic endometritis
Chronic endometritis is low-grade inflammation of the uterine lining driven by persistent bacteria. Unlike acute postpartum cases, this form rarely produces fever or dramatic pain, so symptoms stay subtle.
Patients often report ongoing pelvic discomfort, irregular spotting, or increased discharge. Some experience no outward signs at all, which delays recognition.
The 2025 Frontiers in Endocrinology review notes that these non-specific complaints overlap with multiple pelvic disorders, leaving endometritis off routine checklists.
Diagnostic gaps in standard care
Ultrasound and basic exams seldom reveal chronic endometritis. Detection requires an endometrial biopsy paired with CD138 staining to identify plasma cells.
Most gynecology practices do not order this test unless fertility treatment has already failed. The result is repeated negative workups while inflammation continues.
RRM Academy clinicians point out that without the biopsy, cases stay labeled “unexplained” even when the underlying cause sits in the uterine lining.
Link to fertility and pregnancy loss
Chronic endometritis interferes with embryo implantation and raises miscarriage risk. Studies tracking recurrent pregnancy loss show higher rates of CD138-positive biopsies in this group.
Antibiotic treatment can clear the inflammation and improve subsequent outcomes when the diagnosis is made early. Yet screening remains selective rather than standard.
Patients who finally receive the targeted test often trace prior losses or failed transfers back to undetected endometritis.
Overlap with other pelvic conditions
Endometritis is infection-driven and distinct from endometriosis, though both produce pelvic pain. The difference matters because one responds to antibiotics while the other requires different management.
Many women first pursue endometriosis evaluations only to discover later that biopsy results point elsewhere. Community threads on Reddit document this exact sequence.
Distinguishing the two prevents years of mismatched therapies and keeps attention on the uterine lining where the infection actually lives.
Systemic effects of untreated inflammation
Low-grade endometrial infection can sustain broader inflammatory signals. Patients describe fatigue and generalized discomfort that standard bloodwork does not explain.
Reproductive medicine literature increasingly connects persistent endometritis to wider cytokine activity. The 2025 review tracks how this ongoing response affects implantation and overall well-being.
Clearing the infection often reduces both localized pain and the secondary systemic symptoms that previously lacked a clear source.
Recent clinical literature and updates
The 2025 Frontiers review consolidates evidence on pathogenesis, biopsy criteria, and antibiotic regimens. It highlights that awareness among general providers still lags behind specialist centers.
RRM Academy has pushed for routine CD138 testing in recurrent-loss protocols, citing improved live-birth rates once endometritis is addressed.
These updates arrive as more patients arrive at fertility clinics already frustrated by years of unresolved pelvic pain and negative imaging.
Patient reports and online discussions
Women posting in endometriosis and miscarriage forums describe receiving endometritis diagnoses only after multiple specialists. Many had been told symptoms were stress-related or idiopathic.
Some report quick improvement after targeted antibiotics once the biopsy confirmed plasma cells. Others note that earlier screening could have shortened their diagnostic odyssey.
These accounts match the clinical picture in recent reviews and reinforce the need for broader testing outside tertiary centers.
Barriers to timely diagnosis
Cost, provider familiarity, and lack of insurance coverage for specialized stains keep biopsy rates low. Many offices still reserve the test for IVF failure cases only.
Training gaps mean primary gynecologists may not connect chronic pelvic pain with endometrial infection unless fertility is already on the table.
Expanding education and updating guidelines could shift endometritis from overlooked to routinely considered in pain evaluations.
Practical steps for patients
Women with years of unexplained pelvic pain can ask specifically about endometrial biopsy with CD138 staining. Bringing recent literature to appointments helps frame the request.
Tracking symptoms alongside menstrual patterns and prior procedures gives clinicians clearer context for ordering the test.
Early identification allows antibiotic treatment that targets the infection rather than managing downstream effects indefinitely.
Looking ahead for diagnosis protocols
Endometritis remains under-tested despite clear diagnostic tools and treatment pathways. As awareness grows through recent reviews and patient advocacy, more clinics may adopt routine screening in pain and fertility settings. The shift would convert years of unexplained symptoms into actionable diagnoses for the women still waiting for answers.
